[Value of mfVEP test in pituitary tumors diagnosis]

Anna Piekarska1, Wojciech Lubiński, Wojciech Gosławski

  • 1Z Katedry i Kliniki Okulistyki Pomorskiej Akademii Medycznej w Szczecinie. annapiekarska26@interia.pl

Klinika Oczna
|December 31, 2008
PubMed
Abstract

Insights

The multifocal visual evoked potential (mfVEP) test is effective in diagnosing optic nerve damage in patients with pituitary tumors, showing abnormalities in 53% of cases. This test aids in detecting optic nerve neuropathy when other methods may not.

Area of Science:

  • Ophthalmology
  • Neuroscience

Context:

  • Pituitary tumors can compress the optic nerve, leading to visual field defects and optic nerve neuropathy.
  • Early detection of optic nerve dysfunction is crucial for timely intervention and management of pituitary tumor patients.

Purpose:

  • To assess the utility of the multifocal visual evoked potential (mfVEP) test in identifying optic nerve neuropathy associated with pituitary tumors.

Summary:

  • A study involving 15 patients with pituitary tumors revealed that mfVEP detected abnormalities in 30% of eyes, often as the sole indicator of optic nerve dysfunction.
  • Combined with standard perimetry, mfVEP identified issues in 53% of affected eyes, with significant amplitude reductions noted in superotemporal quadrants compared to controls.

Impact:

  • The mfVEP test demonstrates potential as a valuable diagnostic tool for optic nerve dysfunction in the context of pituitary tumors.
  • Findings suggest mfVEP can complement existing methods, improving the detection rate of visual pathway compromise in this patient population.

Related Concept Videos

Sensitivity, Specificity, and Predicted Value01:13

Sensitivity, Specificity, and Predicted Value

In healthcare diagnostics, laboratory tests play a crucial role in identifying and diagnosing a wide range of medical conditions. However, interpreting test results is not always straightforward. An abnormal test result does not always confirm the presence of a disease, just as a normal result does not guarantee its absence. To assess the reliability of these diagnostic tools, healthcare practitioners rely on two key statistical indicators: sensitivity and specificity.
Sensitivity is the...
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.